Rifampin drug resistance tests for tuberculosis: Challenging the gold standard

Journal of Clinical Microbiology

Volumn 51, Issue 8, 2013, Pages 2633-2640

  Van Deun, Armand ^a,b   Aung, Kya J M ^c   Bola, Valentin ^d   Lebeke, Rossin ^d   Hossain, Mohamed Anwar ^c   De Rijk, Willem Bram ^a   Rigouts, Leen ^a   Gumusboga, Aysel ^a   Torrea, Gabriela ^a   De Jong, Bouke C ^a  

^a INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^b INTERNATIONAL UNION AGAINST TUBERCULOSIS AND LUNG DISEASE   (France)

^c Damien Foundation Bangladesh   (Bangladesh)

^d Coordination Provinciale Lèpre ^*  (Congo)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; RIFAMPICIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATION; CODON; CONTROLLED STUDY; DNA SEQUENCE; GENE AMPLIFICATION; GENE MUTATION; GENOTYPE; HUMAN; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; RPOB GENE; SENSITIVITY AND SPECIFICITY;

ANTITUBERCULAR AGENTS; BANGLADESH; DEMOCRATIC REPUBLIC OF THE CONGO; DNA-DIRECTED RNA POLYMERASES; DRUG RESISTANCE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR DIAGNOSTIC TECHNIQUES; MUTATION, MISSENSE; MYCOBACTERIUM; RIFAMPIN; SPUTUM; TUBERCULOSIS;

EID: 84880609116     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00553-13     Document Type: Article

References (39)

1. Drobniewski F, Nikolayevskyy V, Balabanova Y, Papaventsis D. 2012. Diagnosis of tuberculosis and drug resistance: what can new tools bring us? State of the art series. New tools. Int. J. Tuberc. Lung Dis. 16:860-870.
2. World Health Organization. 2011. Rapid implementation of the Xpert MTB/RIF diagnostic test. Technical and operational "How to" practical considerations. World Health Organization document WHO/HTM/TB/20112. WHO, Geneva, Switzerland.
3. Madison B, Robinson-Dunn B, George I, Gross W, Lipman H, Metchock B, Sloutsky A, Washabaugh G, Mazurek G, Ridderhof J. 2002. Multicenter evaluation of ethambutol susceptibility testing of Mycobacterium tuberculosis by agar proportion and radiometric methods. J. Clin. Microbiol. 40:3976-3979.
4. Van Deun A, Wright A, Zignol M, Weyer K, Rieder HL. 2011. Drug susceptibility testing proficiency in the network of supranational tuberculosis reference laboratories. Int. J. Tuberc. Lung Dis. 15:116-124.
5. Van Deun A, Barrera L, Bastian I, Fattorini L, Hoffmann H, Kam KM, Rigouts L, Rüsch-Gerdes S, Wright A. 2009. Mycobacterium tuberculosis strains with highly discordant rifampin susceptibility test results. J. Clin. Microbiol. 47:3501-3506.
6. Rigouts L, Gumusboga M, de Rijk WB, Nduwamahoro E, Uwizeye C, de Jong B, Van Deun A. 2013. Rifampin resistance missed in automated liquid culture system for Mycobacterium tuberculosis isolates with specific rpoB mutations. J. Clin. Microbiol. 51:2641-2645.
7. Ramaswamy S, Musser JM. 1998. Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tuber. Lung Dis. 79:3-29.
8. Ohno H, Koga H, Kohno S, Tashiro T, Hara K. 1996. Relationship between rifampin MICs and rpoB mutations of Mycobacterium tuberculosis strains isolated in Japan. Antimicrob. Agents Chemother. 40:1053-1056.
9. Williamson DA, Roberts SA, Bower JE, Vaughan R, Newton S, Lowe O, Lewis CA, Freeman JT. 2012. Clinical failures associated with rpoB mutations in phenotypically occult multidrug-resistant Mycobacterium tuberculosis. Int. J. Tuberc. Lung Dis. 16:216-220.
10. Feuerriegel S, Oberhauser B, George AG, Dafae F, Richter E, Rüsch-Gerdes S, Niemann S. 2012. Sequence analysis for detection of first-line drug resistance in Mycobacterium tuberculosis strains from a highincidence setting. BMC Microbiol. 12:90. doi:10.1186/1471-2180-12-90.
11. Mitchison DA. 1969. What is drug resistance? Tubercle 50(Suppl):44-47.
12. Van Deun A, Hamid Salim A, Rigouts L, Rahman M, Fissette K, Portaels F. 2001. Evaluation of tuberculosis control by periodic or routine susceptibility testing in previously treated cases. Int. J. Tuberc. Lung Dis. 5:329-338.
13. Aung KJM, Declerq E, Ali MA, Naha S, Datta Roy SC, Taleb MA, Hossain MA, Rigouts L, Gumusboga A, Van Deun A. 2012. Extension of the intensive phase reduces relapse but not failure in a regimen with rifampicin throughout. Int. J. Tuberc. Lung Dis. 16:455-461.
14. Van Deun A, Salim AH, Daru P, Das APK, Aung KJM, Hossain MA, Rigouts L, Fissette K, Portaels F. 2004. Drug resistance monitoring: combined rates may be the best indicator of programme performance. Int. J. Tuberc. Lung Dis. 8:23-30.
15. Hamid Salim A, Aung KJM, Hossain MA, Van Deun A. 2006. Early and rapid microscopy-based diagnosis of true treatment failure and MDR-TB. Int. J. Tuberc. Lung Dis. 10:1248-1254.
16. Boom R, Sol CJA, Salimans MMM, Jansen CL, Wertheim-van Dillen PME, van der Noordaa J. 1990. Rapid and simple method for purification of nucleic acids. J. Clin. Microbiol. 28:495-503.
17. Durnez L, Stragier P, Roebben K, Ablordey A, Leirs H, Portaels F. 2009. A comparison of DNA extraction procedures for the detection of Mycobacterium ulcerans, the causative agent of Buruli ulcer, in clinical and environmental specimens. J. Microbiol. Methods 76:152-158.
18. Rigouts L, Nolasco O, de Rijk P, Nduwamahoro E, Van Deun A, Ramsay A, Arevalo J, Portaels F. 2007. Newly developed primers for comprehensive amplification of the rpoB gene and detection of rifampin resistance in Mycobacterium tuberculosis. J. Clin. Microbiol. 45:252-254.
19. Sandgren A, Strong M, Muthukrishnan P, Weiner BK, Church GM, Murray MB. 2009. Tuberculosis drug resistance mutation database. PLoS Med. 6(2):e1000002. doi:10.1371/journal.pmed.1000002.
20. Bodadilla-del-Valle M, Ponce-de-Leon A, Arenas-Huertero C, Vargas-Alarcon G, Kato-Maeda M, Small PM, Couary P, Ruiz-Palacios GM, Sifuentes-Osornio J. 2001. rpoB gene mutations in rifampin-resistant Mycobacterium tuberculosis identified by polymerase chain reaction single-stranded conformational polymorphism. Emerg. Infect. Dis. 7:1010-1013.
21. Moghazeh SL, Pan X, Arain T, Stover CK, Musser JM, Kreiswirth BN. 1996. Comparative antimycobacterial activities of rifampin, rifapentine, and KRM-1648 against a collection of rifampin-resistant Mycobacterium tuberculosis isolates with known rpoB mutations. Antimicrob. Agents Chemother. 40:2655-2657.
22. Pozzi G, Meloni M, Iona E, Orrù G, Thoresen OF, Ricci ML, Oggioni MR, Fattorini L, Orefici G. 1999. rpoB mutations in multidrug-resistant strains of Mycobacterium tuberculosis isolated in Italy. J. Clin. Microbiol. 37:1197-1199.
23. Sintchenko V, Chew WK, Jelfs PJ, Gilbert GL. 1999. Mutations in the rpoB gene and rifabutin susceptibility of multidrug-resistant Mycobacterium tuberculosis strains isolated in Australia. Pathology 31:257-260.
24. Taniguchi H, Aramaki H, Nikaido Y, Mizuguchi Y, Nakamura M, Koga T, Yoshida SI. 1996. Rifampicin resistance and mutation of the rpoB gene in Mycobacterium tuberculosis. FEMS Microbiol. Lett. 144:103-108.
25. Yang B, Koga H, Ohno H, Ogawa K, Fukuda M, Hirakata Y, Maesaki S, Tomono K, Tashiro T, Kohno S. 1998. Relationship between antimycobacterial activities of rifampicin, rifabutin and KRM-1648 and rpoB mutations of Mycobacterium tuberculosis. J. Antimicrob. Chemother. 42: 621-628.
26. Yuen LKW, Leslie D, Coloe PJ. 1999. Bacteriological and molecular analysis of rifampin-resistant Mycobacterium tuberculosis strains isolated in Australia. J. Clin. Microbiol. 37:3844-3850.
27. World Health Organization. 2010. Treatment of tuberculosis: guidelines for national programmes, 4th ed. World Health Organization document WHO/HTM/TB/2009.420. WHO, Geneva, Switzerland.
28. Yip CW, Leung KL, Wong D, Cheung DTL, Chu MY, Tang HS, Kam KM. 2006. Denaturing HPLC for high-throughput screening of rifampicin-resistant Mycobacterium tuberculosis isolates. Int. J. Tuberc. Lung Dis. 10:625-630.
29. Jou R, Chen HY, Chiang CY, Yu MC, Su IJ. 2005. Genetic diversity of multidrug-resistant Mycobacterium tuberculosis isolates and identification of 11 novel rpoB alleles in Taiwan. J. Clin. Microbiol. 43:1390-1394.
30. Gagneux S, Davis Long C, Small PM, Van T, Schoolnik GK, Bohannan BJM. 2006. The competitive cost of antibiotic resistance in Mycobacterium tuberculosis. Science 312:1944-1946.
31. van Ingen J, Aarnoutse R, de Vries G, Boeree MJ, van Soolingen D. 2011. Low-level rifampicin-resistant Mycobacterium tuberculosis strains raise a new therapeutic challenge. Int. J. Tuberc. Lung Dis. 15:990-992.
32. Ioerger TR, Koo S, No EG, Chen X, Larsen MH, Jacobs WR, Jr, Sturm AW, Sacchettini JC. 2009. Genome analysis of multi- and extensivelydrug-resistant tuberculosis from KwaZulu-Natal, South Africa. PLoS One 4(11):e7778. doi:10.1371/journal.pone.0007778.
33. Boehme CC, Nabeta P, Hillemann D, Nicol MP, Shenai S, Krapp F, Allen J, Tahirli R, Blakemore R, Rustomjee R, Milovic A, Jones M, O'Brien SM, Persing DH, Ruesch-Gerdes S, Gotuzzo E, Rodrigues C, Alland D, Perkins MD. 2010. Rapid molecular detection of tuberculosis and rifampin resistance. N. Engl. J. Med. 363:1005-1015.
34. Weyer K, Mirzayev F, Migliori GB, van Gemert W, D'Ambrosio L, Zignol M, Floyd K, Centis R, Cirillo D, Tortoli E, Gilpin C, Iragena J, Falzon D, Raviglione M. 22 November 2012. Rapid molecular TB diagnosis: evidence, policy-making and global implementation of Xpert® MTB/RIF. Eur. Respir. J. [Epub ahead of print.] doi:10.1183/09031936.00157212.
35. Theron G, Peter J, van Zyl-Smit R, Mishra H, Streicher E, Murray S, Dawson R, Whitelaw A, Hoelscher M, Sharma S, Pai M, Warren R, Dheda K. 2011. Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting. Am. J. Respir. Crit. Care Med. 184:132-140.
36. Van Rie A, Mellet K, John MA, Scott L, Page-Shipp L, Dansey H, Victor T, Warren R. 2012. False-positive rifampicin resistance on Xpert® MTB/RIF: case report and clinical implications. Int. J. Tuberc. Lung Dis. 16: 206-208.
37. Williamson DA, Basu I, Bower J, Freeman JT, Henderson J, Roberts SA. 2012. An evaluation of the Xpert MTB/RIF assay and detection of falsepositive rifampicin resistance in Mycobacterium tuberculosis. Diagn. Microbiol. Infect. Dis. 74:207-209.
38. Al-Mutairi NM, Ahmad S, Mokaddas E. 2011. Performance comparison of four methods for detecting multidrug-resistant Mycobacterium tuberculosis strains. Int. J. Tuberc. Lung Dis. 15:110-115.
39. Huang WL, Chen HY, Kuo YM, Jou R. 2009. Performance assessment of the GenoType MTBDRplus test and DNA sequencing in detection of multidrug-resistant Mycobacterium tuberculosis. J. Clin. Microbiol. 47:2520-2524.